Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Classical hematology 1CNS 1

Conditions

Lymphoma 68Lymphoma, Non-Hodgkin 53Lymphoma, Large B-Cell, Diffuse 47Hodgkin Disease 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Leukemia, Myeloid, Acute 41Small Cell Lung Carcinoma 37Leukemia 37Burkitt Lymphoma 32Lymphoma, Mantle-Cell 29Lymphoma, Follicular 28Lung Neoplasms 20Carcinoma, Non-Small-Cell Lung 20Multiple Myeloma 19Congenital Abnormalities 18Lymphoma, Large-Cell, Immunoblastic 17Lymphoma, Large-Cell, Anaplastic 17Recurrence 15Lymphoma, B-Cell, Marginal Zone 15Lymphoma, B-Cell 15Leukemia, Lymphocytic, Chronic, B-Cell 15Neuroblastoma 13Neoplasms 13Myelodysplastic Syndromes 11Waldenstrom Macroglobulinemia 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, T-Cell 10Immunoblastic Lymphadenopathy 10Sarcoma 9Myeloproliferative Disorders 9

Interventions

Radiotherapy 2Pyridoxine 2Etoposide 2Cytarabine 2Cyclophosphamide 2sodium thiosulfate 1pegfilgrastim 1pegaspargase 1etoposide phosphate 1Vincristine 1Triptorelin Pamoate 1Rituximab 1Prednisolone 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Celecoxib 1Carboplatin 1Capecitabine 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Drug-Related Side Effects and Adverse Reactions × Etoposide × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡